SMAD3 and colorectal cancer: Subsequently, colorectal cancer cells release TGF-β1 into the tumor microenvironment, where it activates the mothers against decapentaplegic homolog 3 (SMAD3) pathway in memory CD8+ T cells, ultimately impairing their antitumor activity (45).